NMTC
Income statement / Annual
Last year (2024), NeuroOne Medical Technologies Corporation's total revenue was $3.45 M,
an increase of 76.86% from the previous year.
In 2024, NeuroOne Medical Technologies Corporation's net income was -$12.32 M.
See NeuroOne Medical Technologies Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$3.45 M |
$1.95 M |
$171.17 K |
$178.15 K |
$1.93 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$742.00 |
| Cost of Revenue |
$2.37 M
|
$1.50 M
|
$241.96 K
|
$275.90 K
|
$1.86 M
|
$27.57 K
|
$21.67 K
|
$17.63 K
|
$7.74 K
|
$0.00
|
| Gross Profit |
$1.08 M
|
$456.52 K
|
-$70.79 K
|
-$97.75 K
|
$63.12 K
|
-$27.57 K
|
-$21.67 K
|
-$17.63 K
|
-$7.74 K
|
$742.00
|
| Gross Profit Ratio |
0.31
|
0.23
|
-0.41
|
-0.55
|
0.03
|
0
|
0
|
0
|
0
|
1
|
| Research and Development Expenses |
$5.07 M
|
$6.94 M
|
$4.93 M
|
$3.93 M
|
$2.08 M
|
$1.53 M
|
$951.06 K
|
$735.33 K
|
$0.00
|
$2.40 K
|
| General & Administrative Expenses |
$7.79 M
|
$6.75 M
|
$6.71 M
|
$5.92 M
|
$4.75 M
|
$4.28 M
|
$3.22 M
|
$2.34 M
|
$189.32 K
|
$7.94 K
|
| Selling & Marketing Expenses |
$108.99 K
|
$173.43 K
|
$270.61 K
|
$338.84 K
|
$0.00
|
$0.00
|
$322.84 K
|
$0.00
|
-$156.71 K
|
$22.98 K
|
| Selling, General & Administrative Expenses |
$7.90 M
|
$6.93 M
|
$6.98 M
|
$6.26 M
|
$4.75 M
|
$4.28 M
|
$3.54 M
|
$2.34 M
|
$32.61 K
|
$30.92 K
|
| Other Expenses |
$0.00
|
-$1.46 M
|
$31.15 K
|
$0.00
|
$0.00
|
$0.00
|
-$1.30 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$12.97 M
|
$12.41 M
|
$9.96 M
|
$10.12 M
|
$4.90 M
|
$5.81 M
|
$3.19 M
|
$3.07 M
|
$32.61 K
|
$30.92 K
|
| Cost And Expenses |
$15.34 M
|
$13.91 M
|
$10.20 M
|
$10.40 M
|
$4.90 M
|
$5.81 M
|
$3.21 M
|
$3.07 M
|
$32.61 K
|
$30.92 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$228.99 K
|
$0.00
|
$0.00
|
$3.05 K
|
$7.52 M
|
$284.56 K
|
$0.00
|
$1.40 M
|
$0.00
|
$14.02 K
|
| Depreciation & Amortization |
$246.79 K
|
$199.27 K
|
$226.21 K
|
$147.13 K
|
$70.55 K
|
$27.57 K
|
$21.67 K
|
$17.63 K
|
$7.74 K
|
$7.77 K
|
| EBITDA |
-$11.84 M |
-$11.76 M |
-$9.91 M |
-$9.80 M |
-$4.85 M |
-$5.79 M |
-$4.15 M |
-$3.05 M |
-$32.61 K |
-$30.92 K |
| EBITDA Ratio |
-3.43
|
-6.02
|
-57.91
|
-55
|
-2.52
|
0
|
0
|
0
|
0
|
-41.66
|
| Operating Income Ratio |
-3.44
|
-6.12
|
-58.6
|
-57.36
|
-2.54
|
0
|
0
|
0
|
0
|
-41.66
|
| Total Other Income/Expenses Net |
-$430.90 K
|
$95.76 K
|
$31.15 K
|
$270.04 K
|
-$8.74 M
|
-$967.77 K
|
-$2.66 M
|
-$1.99 M
|
$156.71 K
|
$0.00
|
| Income Before Tax |
-$12.32 M
|
-$11.86 M
|
-$10.00 M
|
-$9.95 M
|
-$13.64 M
|
-$6.78 M
|
-$6.83 M
|
-$5.06 M
|
-$32.61 K
|
-$30.92 K
|
| Income Before Tax Ratio |
-3.57
|
-6.07
|
-58.42
|
-55.84
|
-7.08
|
0
|
0
|
0
|
0
|
-41.66
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.00
|
$0.00
|
$15.16 K
|
$0.00
|
| Net Income |
-$12.32 M
|
-$11.86 M
|
-$10.00 M
|
-$9.95 M
|
-$13.64 M
|
-$6.78 M
|
-$6.83 M
|
-$5.06 M
|
-$47.78 K
|
-$62.86 K
|
| Net Income Ratio |
-3.57
|
-6.07
|
-58.42
|
-55.84
|
-7.08
|
0
|
0
|
0
|
0
|
-84.72
|
| EPS |
-0.46 |
-0.65 |
-0.63 |
-0.93 |
-2.52 |
-1.72 |
-2.43 |
-2.3 |
-0.0283 |
-0.0372 |
| EPS Diluted |
-0.46 |
-0.65 |
-0.63 |
-0.93 |
-2.52 |
-1.72 |
-2.43 |
-2.3 |
-0.0283 |
-0.0372 |
| Weighted Average Shares Out |
$26.76 M
|
$18.12 M
|
$16.00 M
|
$10.70 M
|
$5.42 M
|
$3.95 M
|
$2.81 M
|
$2.20 M
|
$1.69 M
|
$1.69 M
|
| Weighted Average Shares Out Diluted |
$26.76 M
|
$18.12 M
|
$16.00 M
|
$10.70 M
|
$5.42 M
|
$3.95 M
|
$2.81 M
|
$2.20 M
|
$1.69 M
|
$1.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
